Mettler-Toledo International Inc. (NYSE:MTD) Receives Consensus Rating of “Hold” from Brokerages

Mettler-Toledo International Inc. (NYSE:MTD) has been given an average rating of “Hold” by the ten ratings firms that are covering the stock, Marketbeat reports. Six analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $1,302.11.

A number of brokerages have recently issued reports on MTD. Wall Street Zen downgraded Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Monday, May 5th. Citigroup raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 price target for the company in a research note on Monday, April 7th. Wells Fargo & Company increased their price target on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an “equal weight” rating in a report on Monday, May 5th. Jefferies Financial Group raised shares of Mettler-Toledo International from an “underperform” rating to a “hold” rating and dropped their price objective for the stock from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Finally, Evercore ISI increased their target price on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research note on Monday, February 10th.

Mettler-Toledo International Trading Down 1.8%

MTD stock opened at $1,115.43 on Tuesday. The firm has a 50 day moving average of $1,096.96 and a 200-day moving average of $1,208.03. The firm has a market capitalization of $23.18 billion, a P/E ratio of 27.52, a price-to-earnings-growth ratio of 3.30 and a beta of 1.40. Mettler-Toledo International has a 12 month low of $946.69 and a 12 month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, topping the consensus estimate of $7.90 by $0.29. The firm had revenue of $883.74 million for the quarter, compared to analysts’ expectations of $876.61 million. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. The business’s quarterly revenue was down 4.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $8.89 earnings per share. Sell-side analysts predict that Mettler-Toledo International will post 42.71 EPS for the current year.

Hedge Funds Weigh In On Mettler-Toledo International

Institutional investors and hedge funds have recently bought and sold shares of the stock. GAMMA Investing LLC boosted its stake in shares of Mettler-Toledo International by 131,246.3% during the first quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier’s stock valued at $456,018,000 after purchasing an additional 385,864 shares during the period. Norges Bank purchased a new stake in Mettler-Toledo International during the 4th quarter valued at $372,954,000. Proficio Capital Partners LLC bought a new stake in Mettler-Toledo International in the 4th quarter worth $163,216,000. Alliancebernstein L.P. increased its position in shares of Mettler-Toledo International by 21.6% in the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock valued at $837,653,000 after acquiring an additional 126,147 shares during the period. Finally, T. Rowe Price Investment Management Inc. raised its stake in shares of Mettler-Toledo International by 36.1% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 363,107 shares of the medical instruments supplier’s stock valued at $444,327,000 after acquiring an additional 96,300 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.